1. CRCINA, INSERM, Université d’Angers, Université de Nantes, Nantes, France
2. LabEx IGO “Immunotherapy, Graft, Oncology”, Nantes, France
3. INSERM, EFS BFC, UMR1098, Interactions Hôte-Greffon-Tumeur/Ingénierie Cellulaire et Génique, Univ. Bourgogne Franche-Comté, Besançon, France
4. Rouen University Hospital, INSERM UMR1245, Institute for Research and Innovation in Biomedicine, Rouen, France
5. Department of Genetics, Rouen University Hospital, Normandy Centre for Genomic and Personalized Medicine, Rouen, France